Search Results 391-400 of 16280 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is is to assess the EPIQ-Affiniti and NG Compact ultrasound systems in a clinical environment and collect clinical data and feedback ...
The Somatic Mutations in Development and Aging Lab of Alexej Abyzov, Ph.D., at Mayo Clinic studies the effects of DNA changes that happen during a person's ...
The purpose of this study is to identify common genetic variants contributing to the risk of glioma. Evaluate gene-gene and gene-environmental interactions with ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
The purpose of this study is to demonstrate haemorrhage detection sensitivity >80% and specificity >80%. Participation eligibility. Participant eligibility ...
All of Us is a service mark of the Department of Health and Human Services.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.